MAMOGRAFIJA SA INTRAVENSKOM PRIMENOM KONTRASTNOG SREDSTVA KAO NOVI STANDARD BRIGE O ZDRAVLJU DOJKE

  • Kristina Stevanović Dom zdravlja „Dr Milutin Ivković“, Beograd, Republika Srbija
  • Bojana Maričić Urgentni centar Univerzitetskog Kliničkog centra Srbije, Republika Srbija
  • Jovana Radovanović Fakultet medicinskih nauka, Univerzitet Kragujevac, Kragujevac, Republika Srbija
Ključne reči: kontrastna mamografija, skrining, karcinom dojke

Sažetak


Kontrastna mamografija (KM) (eng. Contrast-enhanced mammography - CEM) postaje sve više prisutna metoda u dijagnostici karcinoma dojke tokom poslednjih nekoliko decenija, a posebno tokom poslednjih nekoliko godina. Sve je više dokaza o visokoj dijagnostičkoj efektivnosti i senzitivnosti KM u otkrivanju karcinoma dojke. Takođe, nova istraživanja pokazuju sličnost u efektivnosti i senzitivnosti KM u poređenju sa magnetnom rezonancom (MR), uz manje slučajeva lažno pozitivnih rezultata. Kako se primena KM sve više širi, od potencijalne njene primene u skriningu kod žena sa gustim tkivom dojke do određivanja stadijuma maligniteta dojke, sve je više neophodna dobra upućenost u ovu metodu i njenu implementaciju. Ovim preglednim radom biće sagledan značaj KM kako za skrining, tako i za dijagnostičku proceduru, sa posebnim akcentom na sagledavanje njenih prednosti i nedostataka u odnosu na ultrazvuk, standardnu mamografiju i MR.

Reference

Patel BK, Lobbes MBI, Lewin J. Contrast Enhanced Spectral Mammography: A Review.Semin Ultrasound CT MR 2018;39(1):70–79. doi.org/10.1053/j.sult.2017.08.005

Funke M. Diagnostic Imaging of Breast Cancer: An Update. Radiologe. 2016;56:921–938. doi: 10.1007/s00117-016-0134-6

Luczynska E, Piegza T, Szpor J, Heinze S, Popiela T, Kargol J, et al. Contrast-Enhanced Mammography (CEM) Capability to Distinguish Molecular Breast Cancer Subtypes. Biomedicines. 2022;10(10):2384. doi: 10.3390/biomedicines10102384

Sung H, Ferlay J, Siegel R.L, Laversanne M, Soerjomataram I, Jemal A, et al.. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660

Grigoryants NF, Sass S, Alexander J. Novel Technologies in Breast Imaging: A Scoping Review. Cureus. 2023;15(8):e44061. doi: 10.7759/cureus.44061

Steyerova P, Burgetova A. Current imaging techniques and impact on diagnosis and survival —a narrative review. Annals of Breast Sur. 2022; 6: 25. doi: 10.21037/abs-21-2

Dibden A, Offman J, Duffy SW, Gabe R. Worldwide Review and Meta-Analysis of Cohort Studies Measuring the Effect of Mammography Screening Programmes on Incidence-Based Breast Cancer Mortality. Cancers (Basel). 2020; 12(4):976. doi: 10.3390/cancers12040976

Coffey K, Jochelson M. Contrast-enhanced mammography in breast cancer screening. European Journal of Radiology. 2022; 156: 110513. doi.org/10.1016/j.ejrad.2022.110513

Yang M.L, Bhimani C, Roth, R. et al. Contrast enhanced mammography: focus on frequently encountered benign and malignant diagnoses. Cancer Imaging. 2023; 10: 23. doi.org/10.1186/s40644-023-00526-1

Bernardi D, Vatteroni G, Acquaviva A, Valentini M, Sabatino V, Bolengo I. et al. Contrast-enhanced mammography versus MRI in the evaluation of neoadjuvant therapy response in patients with breast cancer: a prospective study. American Journal of Roentgenology, 219(6), 884-894. doi.org/10.2214/AJR.22.27756

Ainakulova A. S, Zholdybay Z. Z, Kaidarova D. R, Inozemtceva N.I, Gabdullina M.O, Zhakenova Z. K. et al. Contrast-enhanced spectral mammography without and with a delayed image for diagnosing malignancy among mass lesions in dense breast. Contemporary Oncology/Współczesna Onkologia. 2021; 25(1): 17-22. doi.org/10.5114/wo.2021.105030

Ackerman LV, Watt AC, Shetty P, Flynn MJ, Burke M, Kambouris A, et al. Breast lesions examined by digital angiography. Work in progress. Radiology 1985;155:65–8. doi.org/10.1097/00004424-198708000-00017

Jong RA, Yaffe MJ, Skarpathiotakis M, Shumak RS, Danjoux NM, Gunesekara A,et al. Contrast-enhanced digital mammography: initial clinical experience. Radiology 2003;228:842–50. doi.org/10.1148/radiol.2283020961

Diekmann F, Freyer M, Diekmann S, Fallenberg EM, Fischer T, Bick U, et al. Evaluation of contrast-enhanced digital mammography. Eur J Radiol. 2011; 78:112–21. doi.org/10.1016/j.ejrad.2009.10.002

Zanardo M, Cozzi A, Trimboli RM, Labaj O, Monti CB, Schiaffino S, et al.. Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review. Insights Imaging 2019; 10: 76. doi.org/10.1186/s13244

Neeter L. M, Raat H. P. J, Alcantara R, Robbe Q, Smidt M. L, Wildberger J. E. et al. Contrast-enhanced mammography: what the radiologist needs to know. BJR| Open. 2021; 3(1), 20210034.doi.org/10.1259/bjro.20210034

Jochelson MS, Lobbes MBI. Contrast-Enhanced mammography: state of the art. Radiology 2021; 299: 36–48. doi: https://doi.org/10.1148/radiol.2021201948

Sickles E.A, D’Orsi C, Bassett L, Appleton C, Berg W, Burnside E. "Acr bi-rads® mammography." ACR BI-RADS® atlas, breast imaging reporting and data system 5 (2013): 2013.

Amir T, Hogan M , Jacobs S, Sevilimedu V, Sung J, Jochelson M.Comparison of False-Positive Versus True-Positive Findings on Contrast-Enhanced Digital Mammography. American Journal of Roentgenology. 2021; 218 (5):24. https://doi.org/10.2214/AJR.21.26847

James J. Contrast-enhanced spectral mammography (CESM)-guided breast biopsy as an alternative to MRI-guided biopsy. Br J Radiol. 2022;95(1132):20211287. doi: 10.1259/bjr.20211287

Hogan MP, Amir T, Sevilimedu V, Sung J, Morris EA, Jochelson MS. Contrast-Enhanced Digital Mammography Screening for Intermediate-Risk Women With a History of Lobular Neoplasia. AJR Am J Roentgenol. 2021;216(6):1486-1491. doi: 10.2214/AJR.20.23480

Jochelson MS, Pinker K, Dershaw DD, Hughes M, Gibbons GF, Rahbar K. et al. Comparison of screening CEDM and MRI for women at increased risk for breast cancer:A pilot study.Eur J Radiol.2017;97:37-43. doi: 10.1016/j.ejrad.2017.10.001

Klang E, Krosser A, Amitai MM, Sorin V, Halshtok Neiman O, Shalmon A, et al. Utility of routine use of breast ultrasound following contrast-enhanced spectral mammography. Clin Radiol. 2018;73(10):908.e11-908.e16. doi: 10.1016/j.crad.2018.05.031

Phillips J, Miller MM, Mehta TS, Fein-Zachary V, Nathanson A, Hori W. et al. Contrast-enhanced spectral mammography (CESM) versus MRI in the high-risk screening setting: patient preferences and attitudes. Clin Imaging. 2017;42:193-197. doi: 10.1016/j.clinimag.2016.12.011

Objavljeno
2024/04/26
Rubrika
Pregledni rad